knowledge -WSS

knowledge

author：Wikipedia 2025-09-28 22:28:54 - browse：8

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Ethical issues complicate the benefits of medical crowdfunding

hotspot

WSS

Covid hospitalizations on the rise, Humana says

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Amazon on where the company's health care bets are headed next

ALS advocates say criticism of new drugs misses bigger picture

My daughter's legacy lives on through her writing, phage therapy

New report analyzes digital physical therapy solutions' effectiveness

explore

knowledge

hotspot

Moonlake's readout produced a cash windfall. Risks remain

The (many) problems with a new study criticizing cancer screening

Activists slam private health insurers over coverage restrictions

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Walensky prepares to leave CDC — and Congress — behind

How to protect patients from sexual assault

What does generative AI mean for health care? We asked experts

Medical device trials still don't enroll enough women, study finds

The high cost of giving birth even with insurance

5 takeaways from STAT's examination of Zynex Medical

entertainment

House transparency, PBM reform bill gains bipartisan support

Readers discuss the intersection of pregnancy and addiction

Medicaid rebukes states for mistakenly disenrolling children

Teladoc has a new CEO, but challenges remain the same

NIH tests clinical research in primary care with $30 million program

Stephen Quake on the Chan Zuckerberg quest to conquer disease

hotspot

hotspot

focus

knowledge